| Mephedrone (4-methylmethcathinone;‘meow meow’): chemical, pharmacological and clinical issues F Schifano, A Albanese, S Fergus, JL Stair, P Deluca, O Corazza, Z Davey, ... Psychopharmacology 214, 593-602, 2011 | 360 | 2011 |
| Novel psychoactive substances of interest for psychiatry F Schifano, L Orsolini, G Duccio Papanti, JM Corkery World Psychiatry 14 (1), 15-26, 2015 | 315 | 2015 |
| Factors impacting antiretroviral therapy adherence among human immunodeficiency virus–positive adolescents in Sub-Saharan Africa: a systematic review N Ammon, S Mason, JM Corkery Public health 157, 20-31, 2018 | 200 | 2018 |
| COVID-19: the hidden impact on mental health and drug addiction S Chiappini, A Guirguis, A John, JM Corkery, F Schifano Frontiers in psychiatry 11, 572335, 2020 | 183 | 2020 |
| The effects of methadone and its role in fatalities JM Corkery, F Schifano, AH Ghodse, A Oyefeso Human Psychopharmacology: Clinical and Experimental 19 (8), 565-576, 2004 | 181 | 2004 |
| Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine O Corazza, F Schifano, P Simonato, S Fergus, S Assi, J Stair, J Corkery, ... Human Psychopharmacology: Clinical and Experimental 27 (2), 145-149, 2012 | 175 | 2012 |
| Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project O Corazza, S Assi, P Simonato, J Corkery, FS Bersani, Z Demetrovics, ... Human Psychopharmacology: Clinical and Experimental 28 (4), 317-323, 2013 | 161 | 2013 |
| An insight into Z-drug abuse and dependence: an examination of reports to the European medicines agency database of suspected adverse drug reactions F Schifano, S Chiappini, JM Corkery, A Guirguis International Journal of Neuropsychopharmacology 22 (4), 270-277, 2019 | 153 | 2019 |
| Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone,“meow meow”) in the United Kingdom F Schifano, J Corkery, AH Ghodse Journal of clinical psychopharmacology 32 (5), 710-714, 2012 | 142 | 2012 |
| Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review L Orsolini, S Chiappini, U Volpe, D De Berardis, R Latini, GD Papanti, ... Medicina 55 (9), 525, 2019 | 138 | 2019 |
| Suicide among drug addicts in the UK A Oyefeso, H Ghodse, C Clancy, JM Corkefy The British Journal of Psychiatry 175 (3), 277-282, 1999 | 120 | 1999 |
| Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002 F Schifano, A Oyefeso, J Corkery, K Cobain, R Jambert‐Gray, G Martinotti, ... Human psychopharmacology: clinical and experimental 18 (7), 519-524, 2003 | 119 | 2003 |
| Trapped in the" K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006) F Schifano, J Corkery, A Oyefeso, T Tonia, AH Ghodse Journal of clinical psychopharmacology 28 (1), 114-116, 2008 | 110 | 2008 |
| Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1, 4-butanediol (1, 4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use JM Corkery, B Loi, H Claridge, C Goodair, O Corazza, S Elliott, F Schifano Neuroscience & Biobehavioral Reviews 53, 52-78, 2015 | 107 | 2015 |
| “Spice,”“kryptonite,”“black mamba”: an overview of brand names and marketing strategies of novel psychoactive substances on the web O Corazza, G Valeriani, FS Bersani, J Corkery, G Martinotti, G Bersani, ... Journal of Psychoactive Drugs 46 (4), 287-294, 2014 | 99 | 2014 |
| Review of deaths related to taking ecstasy, England and Wales, 1997-2000 F Schifano, A Oyefeso, L Webb, M Pollard, J Corkery, AH Ghodse Bmj 326 (7380), 80-81, 2003 | 98 | 2003 |
| Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003) F Schifano, J Corkery, P Deluca, A Oyefeso, AH Ghodse Journal of psychopharmacology 20 (3), 456-463, 2006 | 97 | 2006 |
| Characteristics of deaths associated with kratom use JM Corkery, P Streete, H Claridge, C Goodair, D Papanti, L Orsolini, ... Journal of psychopharmacology 33 (9), 1102-1123, 2019 | 96 | 2019 |
| New/emerging psychoactive substances and associated psychopathological consequences F Schifano, F Napoletano, S Chiappini, A Guirguis, JM Corkery, ... Psychological medicine 51 (1), 30-42, 2021 | 94 | 2021 |
| Abuse of prescription drugs in the context of novel psychoactive substances (NPS): a systematic review F Schifano, S Chiappini, JM Corkery, A Guirguis Brain sciences 8 (4), 73, 2018 | 94 | 2018 |
Ornella CorazzaProfessor of Addiction Science, School of Life and Medical Sciences, University of Hertfordshire在 herts.ac.uk 的电子邮件经过验证
